Jean-Frédéric Chibret
Chief Executive Officer at Théa Pharma GmbH
Network origin in Jean-Frédéric Chibret first degree
Entity | Entity type | Industry | |
---|---|---|---|
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France.
11
| Holding Company | Biotechnology | 11 |
Thea Holding SAS
Thea Holding SAS Financial ConglomeratesFinance Thea Holding operates as a investment company. The company is headquartered in Clermont-Ferrand, France.
8
| Private Company | Financial Conglomerates | 8 |
Thea Pharma NV
Thea Pharma NV Pharmaceuticals: MajorHealth Technology Part of KBC Group NV, Thea Pharma NV is a Belgian pharmaceutical company that specializes in the treatment of eye diseases such as blepharitis, dry eyes, glaucoma, and age-related macular degeneration. The company is based in Wetteren, Belgium and was founded in 2000 by Henri Roger Pierre Chibret. Thea Pharma offers a range of products including medicines, medical devices, cosmetics, and dietary supplements. The company is committed to using fewer preservatives in their products and has expertise in the harmful effects of preservatives. Thea Pharma also has a foundation that supports various projects related to eye health.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Thea Pharmaceuticals Ltd.
Thea Pharmaceuticals Ltd. Pharmaceuticals: OtherHealth Technology Part of Thea Holding SAS, Thea Pharmaceuticals Ltd. is a British company that manufactures and distributes ophthalmic care products. The company is based in Newcastle-under-Lyme, UK. The company was founded in 2008. Thea Pharmaceuticals was acquired by Laboratoires Théa SAS from Vision Pharmaceuticals Ltd. on June 17, 2014.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
Laboratoires Théa SAS
Laboratoires Théa SAS Pharmaceuticals: MajorHealth Technology Laboratoires Théa SAS manufactures and markets eye care products. The firm offers dry eyes, allergy, herpes and eye hygiene. The company was founded by Henri Chibret in 1994 and is headquartered in Clermont-Ferrand, France.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Théa Pharma GmbH
Théa Pharma GmbH Medical DistributorsDistribution Services Théa Pharma GmbH is a research laboratory that specializes in eye health. The private company was founded in 1870 and is based in Berlin, Germany. The CEOs are Jean-Frédéric Chibret and Christoph Kessler. Théa Pharma offers a comprehensive range of treatment free of preservatives that takes into account the precious of the eye. The German company provides further training through its medical library and Théa Akademie online continuous training. Théa Pharma also offers products such as the EasyGrip® multi-dose bottle, which makes handling even more user-friendly, especially for the elderly. The company's anniversary brochure describes 150 years of ophthalmology history based on those of the Chibret family who carries ophthalmology in the genes.
1
| Private Company | Medical Distributors | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Frédéric Chibret via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SPERIAN PROTECTION | Medical Specialties | Director/Board Member | |
ATYR PHARMA, INC. | Pharmaceuticals: Major | President | |
ESSILORLUXOTTICA | Medical Specialties | Director of Finance/CFO | |
Essilor of America, Inc.
Essilor of America, Inc. Medical SpecialtiesHealth Technology Essilor of America, Inc. manufactures lenses and eyeglasses. Its products includes lenses for people with presbyopia; anti-reflective lenses; progressive lenses; eye shape designed lenses; impact resistant lenses; thinner and flatter lenses; and transitions lenses. The firm also offers educational programs and consulting services. The company was founded in 1996 and is headquartered in Dallas, TX. | Medical Specialties | President | |
Eurazeo Investment Manager - EIM SA
Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Managr - EIM SA (Eurazeo IM) is a Venture Capital firm founded in 1997 by Christophe Bavière and part of the Eurazeo Group. Eurazeo Investment Manager - EIM SA is headquartered in Paris with additional offices in Frankfurt, Shanghai and Seoul. The firm is formerly known as Idinvest Partners SA, former AGF Private Equity SA. | Investment Managers | Investment Committee Member | |
INSEAD | College/University | Masters Business Admin Doctorate Degree | |
Essilor Canada Ltd.
Essilor Canada Ltd. Medical SpecialtiesHealth Technology Essilor Canada Ltd. manufactures contact lenses, eye glasses and other eye products. The company's trademark product, Varilux, helps in correction of presbyopia. It was founded in 1972 and is located in Sainte-Foy, Canada | Medical Specialties | President | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Medical/Nursing Services | Corporate Officer/Principal | |
Télécom Paris | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree Undergraduate Degree | |
Omnes Capital SAS /Venture/
Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Private Equity Investor Private Equity Analyst | |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | Director/Board Member | |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Université Catholique de Louvain | College/University | Doctorate Degree | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EOA Holding Co., Inc.
EOA Holding Co., Inc. Electronic ComponentsElectronic Technology Part of EssilorLuxottica SA, EOA Holding Co., Inc. is an American company that manufactures and distributes lenses and ophthalmic optical products. | Electronic Components | Chairman | |
ABATTOIR N.V. | Food: Meat/Fish/Dairy | Director/Board Member | |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Transitions Optical, Inc.
Transitions Optical, Inc. Electronic ComponentsElectronic Technology Transitions Optical, Inc. manufactures photochromic ophthalmic lenses. It offers its products through eye care professionals and retail locations. The firm offers eyeglass lenses and sunglasses and shields. The company was founded in 1990 and is headquartered in Pinellas Park, FL. | Electronic Components | Director/Board Member | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Kurma Biofund FCPR
Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Investment Managers | Corporate Officer/Principal | |
Maisons & Cités d'HLM
Maisons & Cités d'HLM Real Estate DevelopmentFinance Maisons & Cités d'HLM provides real estate services. It offers builds social housing, as well as offers renting, selling, and buying of properties. The company was founded on December 31, 1985 and is headquartered in Douai, France. | Real Estate Development | Chairman | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Groupe de Sup de Co La Rochelle | College/University | Graduate Degree | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
V-Bio Ventures BV
V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures BV is an Independent Venture Capital firm founded in 2015 by Christina Takke and Willem Broekaert. V-Bio Ventures BV is headquartered in Ghent. | Investment Managers | Founder | |
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
Cci France International | Director/Board Member | ||
Insead Business School | College/University | Masters Business Admin | |
French American Chamber of Commerce New England | Director/Board Member | ||
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Biotechnology | Director/Board Member | |
V-Bio Management 1 BV
V-Bio Management 1 BV Financial ConglomeratesFinance Part of V-Bio Ventures BV, V-Bio Management 1 BV functions as an investment holding Belgian company. The company is based in Ghent, Belgium. | Financial Conglomerates | Director/Board Member | |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | President | |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California. | Investment Managers | Director/Board Member |
Statistics
International
France | 29 |
United States | 14 |
Belgium | 7 |
Canada | 2 |
Sweden | 2 |
Sectoral
Health Technology | 24 |
Finance | 10 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 3 |
Operational
Director/Board Member | 125 |
Chairman | 30 |
Corporate Officer/Principal | 25 |
Chief Executive Officer | 16 |
Independent Dir/Board Member | 12 |
Most connected contacts
- Stock Market
- Insiders
- Jean-Frédéric Chibret
- Company connections